Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke

被引：12

作者：

Warlow, C ^{[1
]}

机构：

[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland

来源：

STROKE | 2002年 / 33卷 / 08期

关键词：

D O I：

10.1161/01.STR.0000023120.91460.F3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2137 / 2138

页数：2

共 50 条

[1] Aspirin therapy should be first-line treatment in secondary prevention of stroke - Against
Diener, HC
[J]. STROKE, 2002, 33 (08) : 2138 - 2139
[2] Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention
Wang, Yilong
Chen, Weiqi
Wang, Yongjun
[J]. CURRENT CARDIOLOGY REPORTS, 2015, 17 (10)
[3] Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention
Yilong Wang
Weiqi Chen
Yongjun Wang
[J]. Current Cardiology Reports, 2015, 17
[4] Aspirin and Antiplatelet Agent ResistanceImplications for Prevention of Secondary Stroke
David M. Greer
[J]. CNS Drugs, 2010, 24 : 1027 - 1040
[5] Antiplatelet Therapy in the Secondary Prevention of Stroke
Graeme J. Hankey
[J]. 中国循证医学杂志, 2004, (03) : 150 - 156
[6] Secondary stroke prevention and antiplatelet therapy
Horton, HL
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2567 - 2568
[7] Antiplatelet therapy for secondary stroke prevention
Forbes, CD
[J]. SCOTTISH MEDICAL JOURNAL, 1999, 44 (02) : 54 - 59
[8] Antiplatelet therapy in secondary stroke prevention
Worrall B.B.
Johnston K.C.
[J]. Current Atherosclerosis Reports, 2000, 2 (2) : 104 - 109
[9] Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications
Su, Ya
Cheng, Xin
Dong, Qiang
[J]. CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (11) : 870 - 876
[10] Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings No
Strauss, Martin H.
Hall, Alistair
[J]. STROKE, 2009, 40 (09) : 3161 - 3162

← 1 2 3 4 5 →